Literature DB >> 33740250

Lipid Metabolism and Tumor Antigen Presentation.

Hong Qin1, Yaxi Chen2.   

Abstract

Tumors always evade immune surveillance and block T cell activation in a poorly immunogenic and immunosuppressive environment. Cancer cells and immune cells exhibit metabolic reprogramming in the tumor microenvironment (TME), which intimately links immune cell function and edits tumor immunology. In addition to glucose metabolism, amino acid and lipid metabolism also provide the materials for biological processes crucial in cancer biology and pathology. Furthermore, lipid metabolism is synergistically or negatively involved in the interactions between tumors and the microenvironment and contributes to the regulation of immune cells. Antigen processing and presentation as the initiation of adaptive immune response play a critical role in antitumor immunity. Therefore, a relationship exists between antigen-presenting cells and lipid metabolism in TME. This chapter introduces the updated understandings of lipid metabolism of tumor antigen-presenting cells and describes new directions in the manipulation of immune responses for cancer treatment.

Entities:  

Keywords:  Antigen presentation; Immune response; Lipid metabolism; Tumor microenvironment

Mesh:

Substances:

Year:  2021        PMID: 33740250     DOI: 10.1007/978-981-33-6785-2_11

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  108 in total

Review 1.  Immunometabolism: Cellular Metabolism Turns Immune Regulator.

Authors:  Róisín M Loftus; David K Finlay
Journal:  J Biol Chem       Date:  2015-11-03       Impact factor: 5.157

Review 2.  Recent advances in antigen processing and presentation.

Authors:  Peter E Jensen
Journal:  Nat Immunol       Date:  2007-10       Impact factor: 25.606

Review 3.  Endocytosis mechanisms and the cell biology of antigen presentation.

Authors:  Sven Burgdorf; Christian Kurts
Journal:  Curr Opin Immunol       Date:  2008-01-30       Impact factor: 7.486

4.  Editorial overview: Antigen processing.

Authors:  Gennaro De Libero
Journal:  Curr Opin Immunol       Date:  2018-06       Impact factor: 7.486

Review 5.  Cross-presentation by dendritic cells.

Authors:  Olivier P Joffre; Elodie Segura; Ariel Savina; Sebastian Amigorena
Journal:  Nat Rev Immunol       Date:  2012-07-13       Impact factor: 53.106

Review 6.  SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology.

Authors:  Hitoshi Shimano; Ryuichiro Sato
Journal:  Nat Rev Endocrinol       Date:  2017-08-29       Impact factor: 43.330

7.  Targeting antigen presentation in autoimmunity.

Authors:  Jason R Lees
Journal:  Cell Immunol       Date:  2018-12-11       Impact factor: 4.868

Review 8.  Antigen processing and presentation.

Authors:  Fiorella Kotsias; Ignacio Cebrian; Andrés Alloatti
Journal:  Int Rev Cell Mol Biol       Date:  2019-08-01       Impact factor: 6.813

9.  Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay.

Authors:  M J Bevan
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

10.  Expression regulation of major histocompatibility complex class I and class II encoding genes.

Authors:  Peter J van den Elsen
Journal:  Front Immunol       Date:  2011-10-04       Impact factor: 7.561

View more
  3 in total

1.  The molecular subtypes of triple negative breast cancer were defined and a ligand-receptor pair score model was constructed by comprehensive analysis of ligand-receptor pairs.

Authors:  Weijun Pan; Kai Song; Yunli Zhang; Ciqiu Yang; Yi Zhang; Fei Ji; Junsheng Zhang; Jian Shi; Kun Wang
Journal:  Front Immunol       Date:  2022-08-31       Impact factor: 8.786

2.  Inhibition of UBA6 by inosine augments tumour immunogenicity and responses.

Authors:  Lei Zhang; Li Jiang; Liang Yu; Qin Li; Xiangjun Tian; Jingquan He; Ling Zeng; Yuqin Yang; Chaoran Wang; Yuhan Wei; Xiaoyue Jiang; Jing Li; Xiaolu Ge; Qisheng Gu; Jikun Li; Di Wu; Anthony J Sadler; Di Yu; Dakang Xu; Yue Gao; Xiangliang Yuan; Baokun He
Journal:  Nat Commun       Date:  2022-09-15       Impact factor: 17.694

3.  A Novel Risk Model Based on Lipid Metabolism-Associated Genes Predicts Prognosis and Indicates Immune Microenvironment in Breast Cancer.

Authors:  Zhimin Ye; Shengmei Zou; Zhiyuan Niu; Zhijie Xu; Yongbin Hu
Journal:  Front Cell Dev Biol       Date:  2021-06-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.